Home > Riviste > Journal of Radiological Review > Fascicoli precedenti > Journal of Radiological Review 2021 March;8(1) > Journal of Radiological Review 2021 March;8(1):47-50

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

CASE REPORT   

Journal of Radiological Review 2021 March;8(1):47-50

DOI: 10.23736/S2723-9284.20.00055-X

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

Embolization of hemorrhagic lymphangioleiomyomatotis-associated angiomyolipoma

Gianvito CANDITA 1 , Alessandro MARCUCCI 1, Chiara BOCCACCIO 1, Ilaria CARAMELLA 2

1 University of Pisa, Pisa, Italy; 2 University of Bologna, Bologna, Italy



The treatment of renal angiomyolipoma (AML) in female patients with a concurrent diagnosis of lymphangioleiomyomatosis (LAM) is a topical challenge in medicine. Renal AMLs occurring in patients with LAM are usually multiple, bilateral, fast-growing and present a high risk of life-threatening bleeding, whereby a nephron-sparing procedure is necessary in order to treat the lesion and to prevent the comparison of renal failure due to the treatment. The advent of selective artery embolization (SAE) represents a minimally invasive, effective and safe alternative to surgery or medical treatment.


KEY WORDS: Angiomyolipoma; Embolization, therapeutic; Lymphangioleiomyomatosis

inizio pagina